Jan. 17 (Bloomberg) -- Dr. Reddy's Laboratories Ltd., India's biggest drugmaker, won U.S. regulatory approval to sell its version of Plavix, a blood thinner sold by Bristol-Myers Squibb Co. and Sanofi-Aventis SA.

The U.S. Food and Drug Administration allowed Hyderabad- based Dr. Reddy's to sell tablets of clopidogrel bisulfate, or generic Plavix, the regulator said on its Web site.

To contact the reporter on this story: Suresh Seshadri in Bangalore at Sseshadri1@bloomberg.net.

Last Updated: January 16, 2008 22:54 EST